Licensed pharmaceutical wholesaler and exporter in India New Delhi · Mumbai[email protected]
Oncology

Everolimus

Everolimus is a prescription medicine. Pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitors (ATC code L01EG02). Bio Bridge Pharma supplies it from India to hospitals, licensed importers, distributors and tender buyers outside India.

  • Prescription medicine
  • Named patient supply where allowed

Presentations we supply

  • Tablet 0.25 mg
  • Tablet 0.5 mg
  • Tablet 5 mg
  • Tablet 10 mg

Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.

Send Enquiry for Everolimus

Reference information

Summarised from the product information for Afinitor. Always follow the product information approved in your own country.

Active substance
Everolimus
Pharmacotherapeutic group
Antineoplastic agents, protein kinase inhibitors (ATC code L01EG02)
Authorised uses
  • Hormone receptor-positive advanced breast cancer, with exemestane
  • Neuroendocrine tumours of pancreatic, gastrointestinal or lung origin
  • Advanced renal cell carcinoma
Storage (unopened)
Do not store above 25 °C. Store in the original package to protect from light and moisture.

Supply from Bio Bridge Pharma

  • The registration route and import licence are confirmed for your destination before we make an offer.
  • Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
  • Named patient supply where the destination country's rules allow it.

Sources

  1. Product information for Afinitor: www.ema.europa.eu
Enquiries

Need a medicine supplied outside India?

Send the product, strength and destination country. We confirm the registration route and import licence for that destination, then send our offer.

Send Enquiry